Has Peter Rao, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,886 in general payments to Peter Rao, MD across 474 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Peter Rao, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Peter Rao, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Peter Rao, MD

Interventional Cardiology · Dothan, ALNPI 1932250339

Payments from drug & device makers

$12,886in general payments, 2019–2025

Across 474 payments — averaging $27.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$6K
Merck$518
Pfizer$513
Novartis$486
E.r. Squibb & Sons, L.L.C.$485
AstraZeneca$454
plus $4K from 36 others

$2,021in research payments, 2019–2025

Across 8 payments — averaging $252.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Regeneron$2K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	94	$6,366
Merck	34	$518
Pfizer	35	$513
Novartis	33	$486
E.r. Squibb & Sons, L.L.C.	33	$485
AstraZeneca	25	$454
Boston Scientific	24	$404
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	26	$386
Chiesi USA, Inc.	20	$366
Johnson & Johnson	24	$330
Philips North America LLC	15	$255
Actelion Pharmaceuticals US, Inc.	13	$243
Abiomed	10	$222
Boehringer Ingelheim	10	$176
Amgen	10	$165
Sanofi-aventis U.S. LLC	9	$159
Lexicon Pharmaceuticals, Inc.	6	$134
Shockwave Medical, Inc	2	$127
Abbott	4	$122
Astellas Pharma US Inc	1	$100
Cardiva Medical, Inc.	6	$91
Scpharmaceuticals Inc.	4	$91
Esperion Therapeutics, Inc.	5	$88
Kowa Pharmaceuticals America, Inc.	5	$75
Amarin Pharma, Inc.	4	$71
Braemar Manufacturing, LLC	1	$65
Novo Nordisk	2	$39
Irhythm Technologies, Inc.	2	$33
Inspire Medical Systems, Inc.	1	$33
Bridgebio Pharma, Inc.	2	$32
Atricure, Inc.	2	$32
Cvrx, Inc.	1	$29
Gilead	2	$27
Cordis US CORP.	1	$26
United Therapeutics Corporation	1	$21
Inari Medical, Inc.	1	$19
Bayer	1	$19
Kiniksa Pharmaceuticals International, PLC	1	$18
Cardiovascular Systems Inc.	1	$17
GE HealthCare	1	$17
Siemens Medical Solutions USA, Inc.	1	$15
Akcea Therapeutics, Inc.	1	$14

How this compares

$12,886 in reported general payments places this provider in the 55th percentile of 109 interventional cardiology providers in Alabama.

See all interventional cardiology providers in Alabama →

Medicare billing

Part B allowed, 2024

$335,763

Medicare patients

1,420

Services billed

4,565

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Dothan

Charles MayesDothan$46K
John LedouxMobile$2.3M
Alejandro VasquezHuntsville$1.2M
Michael ButlerHuntsville$919K
Robert FosterBirmingham$553K
Chad AlfordMobile$461K
Mihir KanitkarHuntsville$394K
Brigitta BrottBirmingham$376K
Pochana ReddyHuntsville$293K
Kevin DeandradeMobile$239K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →